Financials

  • Market Capitalization 466.05 M
  • Employee 79
  • Founded 2016
  • CEO N/A
  • Website www.preludetx.com
  • Headquarter Delaware, United States
  • FIGI BBG00K7JY2Q6
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.25
市销率
18.38

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2910
EDIT
Editas Medicine, Inc. - Common Stock
3.35 USD+1.52%+7.03%+28.85%+26.42%514.49 M USD
2919
CCCC
C4 Therapeutics, Inc. - Common Stock
4.10 USD-3.30%+3.02%+18.84%+62.06%504.40 M USD
2935
EVMN
Evommune, Inc. Common Stock
13.42 USD-0.07%-5.16%+20.79%-22.52%487.04 M USD
2948
PRTA
Prothena Corporation plc - Ordinary Shares
9.31 USD+2.42%+0.32%+7.75%+12.58%477.95 M USD

新闻